HCRTR1 and polycystic ovary syndrome: A new study using a PCOS model in rats demonstrated that a combination of the OX1R antagonist SB-334,867 and the OX2R antagonist JNJ-10,397,049 significantly reversed elevated serum testosterone levels in the PCOS rats [14].